CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE
Anno:
2023
We reported a case of 46-year-old women without cardiovascular risk factors, with a diagnosis of relapsed metastatic melanoma undergoing treatment with immune check-point inhibitors (ICI), ipilimumab and nivolumab. A transthoracic echocardiogram was performed before starting the treatment that showing normal indices of biventricular function and a normal value of…